Open Access

Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells

  • Authors:
    • Bo Fan
    • Sifeng Shi
    • Xiaofei Shen
    • Xiaolong Yang
    • Na Liu
    • Guixia Wu
    • Xiaojuan Guo
    • Ning Huang
  • View Affiliations

  • Published online on: November 5, 2018     https://doi.org/10.3892/ol.2018.9668
  • Pages: 1160-1166
  • Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We investigated the effect of high mobility group protein N2 (HMGN2) on the proliferation and apoptosis of the human MCF-7 breast cancer cell line, and its effect on tumor growth in a subcutaneous heterotopic transplantation tumor model of breast cancer. The cell viability assay was used to verify the effect of the recombinant human HMGN2 on MCF-7 cell proliferation. The Transwell chamber assay was used to verify the effect of HMGN2 on MCF-7 cell migration. Flow cytometry and Hoechst staining were used to detect the effect of HMGN2 on MCF-7 cell apoptosis. MCF-7 was injected to establish a subcutaneous heterotopic transplantation tumor model of breast cancer in nude mice. The size, weight and volume of tumor in each group were compared after the administration of different concentrations of HMGN2 solution around the tumor tissue at day 1, 3, 5 and 7. The tumor tissue was removed and cut into sections, and the apoptotic cells in tumors of nude mice were detected by a TUNEL kit. The CCK-8 assay showed that HMGN2 at different concentrations inhibited the proliferation of the MCF-7 breast cancer cells, and the proliferation of MCF-7 cells were significantly inhibited when the concentration of HMGN2 reached 3 µg/ml (P<0.01). The Transwell chamber assay showed that 3 µg/ml of HMGN2 significantly decreased the migration capacity of MCF-7 cells (P<0.01). Flow cytometry and Hoechst staining showed that 3 µg/ml of HMGN2 significantly increased apoptosis of MCF-7 cells (P<0.01). After the nude mouse model of breast cancer was established, HMGN2 at different concentrations was injected around the tumor tissue at day 1, 3, 5 and 7. We demonstrated that the growth of breast cancer was significantly inhibited when the concentration of HMGN2 reached 15 µg/ml. TUNEL staining showed that the number of apoptotic cells in the 15 µg/ml dose group was significantly higher than that in the control group (P<0.01). Therefore, in vitro and in vivo experiments proved that recombinant human HMGN2 could significantly inhibit the proliferation and migration of breast cancer cells, which increased the apoptosis of breast cancer cells and exerted anti-breast cancer effects, which enriched our understanding of the biological roles of HMGN2.

References

1 

Sawada T, Akashi S, Nakamura S, Kuwayama T, Enokido K, Yoshida M, Hashimoto R, Ide T, Masuda H, Taruno K, et al: Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women. Breast Cancer. 24:708–713. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Göhler S, Da Silva Filho MI, Johansson R, Enquist-Olsson K, Henriksson R, Hemminki K, Lenner P and Försti A: Functional germline variants in driver genes of breast cancer. Cancer Causes Control. 28:259–271. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Melgaard D: What is the effect of treating secondary lymphedema after breast cancer with complete decongestive physiotherapy when the bandage is replaced with Kinesio Textape? - A pilot study. Physiother Theory Pract. 32:446–451. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Yao L, Chi Y, Hu X, Li S, Qiao F, Wu J and Shao ZM: Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer. Oncotarget. 7:53895–53902. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Wei D, Zhang P, Zhou M, Feng Y and Chen Q: HMGN2 protein inhibits the growth of infected T24 cells in vitro. J Cancer Res Ther. 10:299–304. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Hewson C, Capraro D, Burdach J, Whitaker N and Morris KV: Nuclear protein HMGN2 attenuates pyocyanin-induced oxidative stress via Nrf2 signaling and inhibits Pseudomonas aeruginosa internalization in A549 cells. Free Radic Biol Med. 3:87–96. 2016.

7 

Hu A, Dong X, Liu X, Zhang P, Zhang Y, Su N, Chen Q and Feng Y: Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma. Oncol Lett. 7:115–120. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Dong X, Liu X, Zhang Y, Zhang P, Lu L, Li X, Huang P and Feng Y: Study on prohibition of high mobility group chromosomal protein N2 against human oral squamous cell carcinoma in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi. 31:91–95. 2013.(In Chinese). PubMed/NCBI

9 

Saito A, Suzuki HI, Horie M, Ohshima M, Morishita Y, Abiko Y and Nagase T: An integrated expression profiling reveals target genes of TGF-β and TNF-α possibly mediated by microRNAs in lung cancer cells. PLoS One. 9:335–349. 2014. View Article : Google Scholar

10 

Kanagesan S, Aziz SB, Hashim M, Ismail I, Tamilselvan S, Alitheen NB, Swamy MK, Purna Chandra and Rao B: Synthesis, characterization and in vitro evaluation of manganese ferrite (MnFe2O4) nanoparticles for their biocompatibility with murine breast cancer cells (4T1). Molecules. 21:3122016. View Article : Google Scholar : PubMed/NCBI

11 

Haricharan S, Lei J and Ellis M: Mammary ductal environment is necessary for faithful maintenance of estrogen signaling in ER+ breast cancer. Cancer Cell. 29:249–250. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Qiao G, Cong Y, Zou H, Lin J, Wang X, Li X, Li Y and Zhu S: False-negative frozen section of sentinel lymph node biopsy in a Chinese population with breast cancer. Anticancer Res. 36:1331–1337. 2016.PubMed/NCBI

13 

Wu J, Kim S, Kwak MS, Jeong JB, Min HJ, Yoon HG, Ahn JH and Shin JS: High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles. J Biol Chem. 289:20000–20011. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Schauwecker SM, Kim JJ, Licht JD and Clevenger CV: Histone H1 and chromosomal protein HMGN2 regulate prolactin-induced STAT5 transcription factor recruitment and function in breast cancer cells. J Biol Chem. 297:15–20. 2016.

15 

Shimahara H, Hirano T, Ohya K, Matsuta S, Seeram SS and Tate S: Nucleosome structural changes induced by binding of non-histone chromosomal proteins HMGN1 and HMGN2. FEBS Open Bio. 3:184–191. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Kulkeaw K, Inoue T, Mizuochi C, Horio Y, Ishihama Y and Sugiyama D: Ectopic expression of Hmgn2 antagonizes mouse erythroid differentiation in vitro. Cell Biol Int. 36:195–202. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Wu G, Cao Y, Fan B, Zheng F, Gao X, Liu N, Liu X and Huang N: High-mobility group protein N2 (HMGN2) inhibited the internalization of Klebsiella pneumoniae into cultured bladder epithelial cells. Acta Biochim Biophys Sin (Shanghai). 43:680–687. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Musselman CA and Kutateladze TG: Methyl fingerprinting of the nucleosome reveals the molecular mechanism of high-mobility group nucleosomal-2 (HMGN2) association. Proc Natl Acad Sci USA. 108:12189–12190. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Dal Cin P, Fusco A, Belge G, Chiappetta G, Fedele M, Pauwels P, Bullerdiek J and Van den Berghe H: Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid. Genes Chromosomes Cancer. 24:286–289. 1999. View Article : Google Scholar : PubMed/NCBI

20 

Subramanian M, Gonzalez RW, Patil H, Ueda T, Lim JH, Kraemer KH, Bustin M and Bergel M: The nucleosome-binding protein HMGN2 modulates global genome repair. FEBS J. 276:6646–6657. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

January 2019
Volume 17 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Fan, B., Shi, S., Shen, X., Yang, X., Liu, N., Wu, G. ... Huang, N. (2019). Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells. Oncology Letters, 17, 1160-1166. https://doi.org/10.3892/ol.2018.9668
MLA
Fan, B., Shi, S., Shen, X., Yang, X., Liu, N., Wu, G., Guo, X., Huang, N."Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells". Oncology Letters 17.1 (2019): 1160-1166.
Chicago
Fan, B., Shi, S., Shen, X., Yang, X., Liu, N., Wu, G., Guo, X., Huang, N."Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells". Oncology Letters 17, no. 1 (2019): 1160-1166. https://doi.org/10.3892/ol.2018.9668